FDA Commissioner: Patient Safety Must Be Prioritized Over Job Creation
Philadelphia Inquirer report.
Dr. Hamburg was joined by Paul Glover of Health Canada and Guido Rasi of the European Medicines Agency at the Drug Information Association's 48th annual meeting.
The FDA was recently scrutinized by Congressional members who believe the agency has impeded job creation by shutting down plants with quality control problems. Dr. Hamburg stressed quality concerns, such as glass shards and metal fractures in tobacco products, could not be ignored by the FDA and other regulators.
Mr. Glover added a universal reporting mechanism could more quickly alert regulators about adverse events and promote patient safety around the world.
More Articles on Patient Safety:AHRQ 2011 State Snapshots Spotlight Healthcare Quality, Population Health
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
New From Becker's Infection Control & Clinical Quality
AHRQ's ASC safety program enrollment now openRead Now
- AmSurg stock price target raised to $65, MFC dividend & more – 5 recent ASC company key notes
- Job opening: ASC Administrator - Connecticut Surgery Center
- 10 trends in knee arthroscopy reimbursement & coding
- Supply management optimization: ASC challenges & solutions
- 6 foundational components to determining startup success